Lower riskDrug recall · FDA · Published May 18, 2026
Eugia recalls Lidocaine injection due to label scanning issues
Eugia US LLC recalls Lidocaine HCl Injection 2% vials due to label wrap covering barcode, making scanning difficult. Affected units have specific NDC and lot numbers.
“Eugia recalls Lidocaine injection due to label scanning issues.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31299-eugia-recalls-lidocaine-injection-due-to-label-scanning-issues. Based on FDA recall #D-0552-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0552-2026%22&limit=1).
Eugia US LLC, on behalf of the Food and Drug Administration, is recalling Lidocaine HCl Injection vials because the label wrap obscures the barcode. The FDA announced this Class III recall on May 18, 2026.
How to tell if you have it
Brand: Eugia
Product: Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial
NDC: 55150-164-02
Lot codes: 3LC26029A (exp Feb-2029) and 3LC26031A (exp Mar-2029)
Quantity: 168,300 vials
The hazard
The label wrap covers the barcode on the Lidocaine HCl Injection vials, making it difficult to scan. The FDA classified this as a Class III recall.
Context
GovInfoNow's records show Eugia US LLC has issued 14 other recalls since December 28, 2022. Recent brand recalls include Gentamicin Injection due to stability failure on May 29, 2025, and Tirofiban Injection for out-of-specification results on April 21, 2025. Other recent recalls of similar products include Asclemed Lidolog Kit (July 15, 2026), Asclemed Lidocaine HCl Injection (June 8, 2026), and American Regent Levocarnitine Injection (April 16, 2026).
How to tell if you have this one
Check for NDC 55150-164-02 with lot numbers 3LC26029A (expires Feb 2029) or 3LC26031A (expires Mar 2029). The product is a single-dose vial for prescription use only.
Brand
Eugia
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Label Scanning
Ensure the label wrap does not cover the barcode for proper scanning. If the barcode is obscured, contact your pharmacy for assistance.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “US Nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 23 days after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0552-2026 (May 18, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0552-2026 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.